<< Previous article
12th International F...
Next article > >
Evaluation, Validati...

Pharmaceutical Microbiology East Coast

Pharmaceutical Microbiology

: 10 Apr 2019 - 11 Apr 2019

: Boston, United States

Sector: Pharmaceutical

Type: Conference


The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding.

 

Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation.

Event Hashtag: #SMiPharmaMicroEC

 

At the 2nd Annual Pharmaceutical Microbiology Conference, you will gain insight into:

  • Design, validation and implementation of a documented and approved disinfectant programme
  • Effective use of environmental monitoring data trending
  • Rapid microbial methods
  • Challenges with endotoxin control
  • Advances in sterility assurance technology
  • Current regulations, challenges and trends in mycoplasma safety testing
  • A "deep dive" case study of atypical, low-level mold contamination

FEATURED SPEAKERS INCLUDE:

  • Cheryl Essex, Head of Microbiological Control for Biologic Drugs, Sanofi
  • Frederic Ayers, Consultant Scientist, Eli Lilly and Company • Christopher Day, Group Leader, ASO Microbiology, Bristol-Myers Squibb
  • Elia Sanchez, QC Microbiology Senior Manager, Genentech
  • Clyde Schultz, Adj Professor, University of Calgary and Director Quality Assurance, Celgene
  • Andrew Bartko, Research Leader, Battelle Memorial Institute

KEY TOPICS FOR 2018 INCLUDE:

  • Regulatory considerations for contamination control
  • Revision of Annex 1 and impact on pharmaceutical microbiology
  • Contamination control strategies and case studies
  • Microbiological methods
  • Regulations of endotoxin detection methods
  • Environmental monitoring
  • Rapid microbial methods
  • Sterility assurance
  • Risk mitigation for mycoplasma and animal sera

Plus 2 half day interactive workshops on Friday, November 12th 2019.

Workshop A: Mold Contamination Challenges - Led by: Microrite Inc

Workshop B: Microbiological Control of GMP using Vapour Phase Hydrogen Peroxide bio-Decontamination – Led by: PHSS & Franz Ziel GmbH

 

WHO SHOULD ATTEND

Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist

 

EARLY BIRD-RATES

  • BOOK BY 14TH DECEMBER AND SAVE £400
  • BOOK BY 31ST JANUARY AND SAVE £200
  • BOOK BY 28TH FEBRUARY AND SAVE £100

Find out more / Register here:

Venue

Boston
United States


Organizer

SMi Ltd.
Phone: +44 0 207 827 6186
Email: events@smi-online.co.uk
Visit: https://www.smi-online.co.uk/pharmaceuticals/


<< Previous article
12th International F...
Next article > >
Evaluation, Validati...